Here we are with another incredible year in the books. For those who’ve been with us since the beginning, you’ll know that 2023 brought all-new functional aesthetic technologies, conferences, and clinical developments to the BENEV community. To put it simply: 2023 was a fruitful year.
We launched two new additions, Viviscal™PRO for thinning hair and EXO Balm for post-treatment recovery. We hosted our very first Miracu® Aesthetic Elite Summit in Miami Beach, Florida, and added nearly 50 publications to our ever-growing portfolio of clinical studies and media features. (Cheers to that this New Year’s Eve!)
Yes, BENEV is dominating the medical aesthetics world at a rapid pace, but let’s also acknowledge the fact that this is a $15.4 billion industry—projected to reach $25.9 billion by 2028. Botox, plastic surgery, and other less invasive procedures (like laser facials) were once considered “extreme,” but anti-aging treatments are now widely accepted by all genders of many generations.
No one wants to see themselves age. So if you can preserve your youth and retain your confidence, then why not treat yourself to a treatment or two?
BENEV was established in 2000 as an FDA-registered pharmaceutical, cosmeceutical, and medical device company. Our corporation was founded with an intent to provide innovative, results-driven products to the global aesthetic market. We look beyond the latest fads and beauty trends, and instead, focus on creating technologies that stand the test of time—always adding value to your practice and reliably delivering outcomes that surpass patients’ wildest dreams.
“All BENEV products are developed, formulated, and manufactured in our own FDA-registered lab in compliance with the FDA’s Good Manufacturing Practices.”
Comments